Oncology
David Hong, M.D.
Professor (tenure), Department of Investigational Cancer Therapeutics, Division of Cancer Medicine; Deputy Chair, Department of Investigational Cancer Therapeutics
David S. Hong, MD, is a Professor (tenure) and Deputy Chair in the Department of Investigational Cancer Therapeutics within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. He specializes in medical oncology, with a focus on phase I clinical trials, novel drug development, and precision oncology. Dr. Hong is highly rated for expertise in 36 conditions, including Familial Pancreatic Cancer, Pleuropulmonary Blastoma, *Lung Cancer
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (2007)
- Internal Medicine (2002)
Education & Training
- Albert Einstein College of Medicine — M.D., 1999
- The University of Texas MD Anderson Cancer Center — Fellowship, Medical Oncology (Chief Medical Oncology Fellow, 2004-2005)
- Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (2002-2005)
- Thomas Jefferson University — Residency, Internal Medicine
- Clinical Residency, Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania (1999-2001)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- University of Texas MD Anderson Cancer Center
Languages
English
Experience
25+ years in practice